MENU
Anatomy
Anesthesiology
Biochemistry
Biomedical Informatics
Biophysics
Cell Biology
Clinical Cases
Dentistry
Dermatovenerology
Emergency Medicine
Family Medicine
Forensic Medicine
Gynecology and Obstetrics
Histology and Embryology
History of Medicine
Human Genetics
Hygiene
Infectious Diseases
Internal Medicine
Medical Deontology and Philosophy
Medical Psychology
Microbiology and Immunology
Neurology
Occupational Medicine
Oncology
Ophthalmology
Orthopaedics
Otorhinolaryngology
Pathology
Pathophysiology
Pediatrics
Pharmacology and Experimental Toxicology
Physical and Rehabilitation Medicine
Physiology
Psychiatry
Radiology
Social Medicine
Surgery
Toxicology
Research papers
Clinical research paper
Preclinical research paper
Sponsored articles
Archive » 1995 » 4 » | Archive » Medical field » Fields » Infectious Diseases »

Treatment of Hospital-Acquired Pneumonia

 
Abstract:

This post is also available in: enEnglish slSlovenščina (Slovenian)

Hospital-acquired pneumonia accounts for significant morbidity and mortality in hospitalized patients. Gram-negative bacilli and Staphylococcus aureus are the most common isolates in these patients. Since the etiology of the disease is usually unknown, empirical broad-spectrum antibiotic therapy is given based on the severity of illness, time of onset, specific risk factors and local prevalence of pathogens. Treatment with a single broad-spectrum antibiotic agent (third-generation of cephalosporins, carbapenemes and fluoroquinolons) is recommended in the absence of specific risk factors and Pseudomonas aerugi­nosa. Combination treatment modalities with beta-lactam antibiotics and aminoglycosides is still the cornerstone of empirical antibiotic treat­ment of severe hospital-acquired pneumonia.

Authors:
Muzlovič Igor

Keywords:
pneumonia – therapy, antibiotics, cross infection, hospitals

Cite as:
Med Razgl. 1995; 34: 521–8.

Download PDF >>
© 2020 Društvo Medicinski razgledi | Na vrh strani / To top ↑